Kaca W, Roth R
Department of Laboratory Medicine, University of California School of Medicine, San Francisco, USA.
Biochim Biophys Acta. 1995 Aug 17;1245(1):49-56. doi: 10.1016/0304-4165(95)00077-o.
Purified human hemoglobin is being developed as an alternative to transfusions of homologous erythrocytes. However, toxicity associated with infusion of hemoglobin has limited the development of this resuscitation fluid. Some observed toxicities, including activation of the complement cascade, have been associated with contamination of hemoglobin solutions by bacterial endotoxin. Recent studies have demonstrated complex formation between hemoglobin and endotoxin, and have documented a resultant increase in the ability of endotoxin to activate coagulation, stimulate tissue factor production by human peripheral blood mononuclear cells, and stimulate tissue factor activity and protein synthesis in cultured human endothelial cells. The process of hemoglobin enhancement of endotoxin toxicity suggests a possible mechanism by which the consequences of endotoxin contamination of hemoglobin solutions, including complement activation, could be magnified. Therefore, we studied the potential of hemoglobin to either fix complement directly, or modify the ability of endotoxin to fix complement. Human crosslinked and native hemoglobins, at concentrations between 0.2 mg/ml and 3 mg/ml, were shown to fix complement. Complement fixation by hemoglobin was identical in normal human serum or in factor B-depleted serum, suggesting that fixation occurred via the classical pathway of complement activation. Complement fixation then was examined with a battery of smooth and rough endotoxins tested in the absence and presence of hemoglobin. Addition of hemoglobin to a solution of a rough Salmonella endotoxin partial structure, from which a single fatty acid had been hydrolyzed from the lipid A portion of the macromolecule, resulted in decreased efficiency of complement fixation. However, addition of hemoglobin had little or no effect on the intrinsic complement fixing abilities of eight other smooth endotoxins, rough endotoxins, or endotoxin partial structures. Our results demonstrated the ability of hemoglobin to fix complement at hemoglobin concentrations which would be achieved during infusion for resuscitation, but failed to demonstrate a reproducible effect of hemoglobin on the activation of complement by endotoxin.
纯化的人血红蛋白正在被开发作为同种红细胞输血的替代品。然而,与血红蛋白输注相关的毒性限制了这种复苏液的发展。一些观察到的毒性,包括补体级联的激活,与细菌内毒素污染血红蛋白溶液有关。最近的研究表明血红蛋白与内毒素之间形成复合物,并记录了内毒素激活凝血、刺激人外周血单核细胞产生组织因子以及刺激培养的人内皮细胞中组织因子活性和蛋白质合成能力的相应增加。血红蛋白增强内毒素毒性的过程提示了一种可能的机制,通过该机制血红蛋白溶液内毒素污染的后果(包括补体激活)可能会被放大。因此,我们研究了血红蛋白直接固定补体或改变内毒素固定补体能力的潜力。浓度在0.2mg/ml至3mg/ml之间的人交联血红蛋白和天然血红蛋白被证明可固定补体。在正常人血清或缺乏因子B的血清中,血红蛋白的补体固定情况相同,这表明固定是通过补体激活的经典途径发生的。然后,在有无血红蛋白的情况下,用一系列光滑和粗糙的内毒素检测补体固定情况。将血红蛋白添加到一种粗糙的沙门氏菌内毒素部分结构的溶液中,该结构的脂多糖A部分的一个脂肪酸已被水解,导致补体固定效率降低。然而,添加血红蛋白对其他八种光滑内毒素、粗糙内毒素或内毒素部分结构的固有补体固定能力几乎没有影响。我们的结果表明,在复苏输注过程中可达到的血红蛋白浓度下,血红蛋白具有固定补体的能力,但未能证明血红蛋白对内毒素激活补体有可重复的影响。